title: Response to Letter to the Editor on "Rivaroxaban Use for Thromboprophylaxis Is Associated With Early Periprosthetic Joint Infection".
authors.affiliation: Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio.
authors.forename: Alison K
authors.initials: AK
authors.lastname: Klika
authors.affiliation: Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio.
authors.forename: Olubusola
authors.initials: O
authors.lastname: Brimmo
authors.affiliation: Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio.
authors.forename: Trevor G
authors.initials: TG
authors.lastname: Murray
authors.affiliation: Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio.
authors.forename: Robert
authors.initials: R
authors.lastname: Molloy
authors.affiliation: Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio.
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Higuera
mesh_terms: D001170:Arthritis, Infectious; D019645:Arthroplasty, Replacement, Knee; D006801:Humans; D009025:Morpholines; D000069552:Rivaroxaban
chemical_list: D009025:Morpholines; D000069552:Rivaroxaban